D&D Pharmatech (347850.KQ)
KRW 47200.0
(0.21%)
KRW 47200.0
(0.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -9.11 Billion | -53.08 Billion | -51.94 Billion | -48.57 Billion | -22.02 Billion |
| Net Income | 4.49 Billion | -163.51 Billion | -72.04 Billion | -66.99 Billion | -6.35 Billion |
| Depreciation & Amortization | 4.42 Billion | 13.73 Billion | 11.9 Billion | 11.34 Billion | 7.85 Billion |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 2.22 Billion | 1.43 Billion | 1.69 Billion | 1.23 Billion | 601.82 Million |
| Change in working capital | -2.58 Billion | -2.67 Billion | 6.2 Billion | 2.65 Billion | -2.49 Billion |
| Other non-cash items | 1.03 Billion | 2.22 Billion | 752.17 Million | 4.89 Billion | -21.62 Billion |
| Investing Cash Flow | 268.14 Million | -478.88 Million | -1.95 Billion | -3.33 Billion | -25.42 Billion |
| Investments in PPE | -45.22 Million | -718.91 Million | -2.21 Billion | -3.1 Billion | -1.51 Billion |
| Acquisitions | - | - | - | - | -18.18 Billion |
| Investment purchases | - | - | - | - | -5.17 Billion |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -9.84 Million | 232.99 Million | 263.01 Million | -225.26 Million | -602.07 Million |
| Financing Cash Flow | -629.91 Million | 1.98 Billion | 67.69 Billion | 105.58 Million | 157.38 Billion |
| Debt repayment | -1 Billion | -3.21 Billion | -6.32 Billion | -662.13 Million | -320.49 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 147 Million | 3.01 Billion | - | 16.73 Billion |
| Other Financing Activities | -4.66 Million | -510.00 | -10.00 | 80.00 | 157.7 Billion |
| Accounts receivables | -3.61 Billion | -231.5 Million | 897.48 Million | 195.91 Million | -118.24 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | 1.03 Billion | -2.43 Billion | 5.3 Billion | 2.46 Billion | -2.37 Billion |
| Cash at beginning of period | 25.5 Billion | 75.95 Billion | 60.61 Billion | 113.05 Billion | 3.29 Billion |
| Cash at end of period | 15.64 Billion | 25.5 Billion | 75.95 Billion | 60.61 Billion | 113.05 Billion |
| Capital Expenditure | -45.22 Million | -718.91 Million | -2.21 Billion | -3.1 Billion | -1.51 Billion |
| Effect of forex changes on cash | -382.5 Million | 1.12 Billion | 1.55 Billion | -638.45 Million | -173.4 Million |
| Net cash flow / Change in cash | -9.86 Billion | -50.45 Billion | 15.34 Billion | -52.44 Billion | 109.75 Billion |
| Free Cash Flow | -9.16 Billion | -53.8 Billion | -54.16 Billion | -51.68 Billion | -23.54 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.78 Billion | -5.61 Billion | 4.49 Billion | 198.01 Million | -167.79 Million | 17.58 Billion |
| Depreciation & Amortization | 1.36 Billion | 1.36 Billion | 4.42 Billion | 1.09 Billion | 1.08 Billion | 1.12 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 20.11 Million | 27.4 Million | 2.22 Billion | 343.41 Million | 249.83 Million | 376.43 Million |
| Change in working capital | -506.02 Million | -506.02 Million | -2.58 Billion | 138.01 Million | -3.77 Billion | 524.64 Million |
| Other non-cash items | 679.88 Million | 505.31 Million | 1.03 Billion | 167.91 Million | -24.6 Million | -22.08 Billion |
| Investing Cash Flow | -74.52 Million | -74.52 Million | 268.14 Million | 121.57 Million | 168.6 Million | -11.02 Million |
| Investments in PPE | -20.89 Million | -20.89 Million | -45.22 Million | -13.11 Million | -1.91 Million | -15.09 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -53.63 Million | -53.63 Million | -9.84 Million | 1.98 Million | -19.97 Million | 4.07 Million |
| Financing Cash Flow | 18.09 Billion | 18.09 Billion | -629.91 Million | -408.18 Million | -386.11 Million | 82.19 Million |
| Debt repayment | - | - | -1 Billion | -408.18 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 18.09 Billion | 18.09 Billion | -4.66 Million | -408.18 Million | - | 82.19 Million |
| Accounts receivables | 123.49 Million | 123.49 Million | -3.61 Billion | -2.61 Billion | - | -590.42 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -629.51 Million | -629.51 Million | 1.03 Billion | 2.75 Billion | - | 1.11 Billion |
| Cash at beginning of period | - | 15.64 Billion | 25.5 Billion | 18.61 Billion | 21.09 Billion | - |
| Cash at end of period | 13.84 Billion | 29.48 Billion | 15.64 Billion | 15.64 Billion | 18.61 Billion | -2.2 Billion |
| Capital Expenditure | -20.89 Million | -20.89 Million | -45.22 Million | -13.11 Million | -1.91 Million | -15.09 Million |
| Effect of forex changes on cash | 52.61 Million | 52.61 Million | -382.5 Million | -629.1 Million | -156.82 Million | 201.71 Million |
| Net cash flow / Change in cash | 13.84 Billion | 13.84 Billion | -9.86 Billion | -2.96 Billion | -2.48 Billion | -2.2 Billion |
| Free Cash Flow | -4.24 Billion | -4.24 Billion | -9.16 Billion | -2.06 Billion | -2.11 Billion | -2.49 Billion |
RMC
1936
SKL
SCPH
PCPDF
HRB